Regulation of skin γδ T cell proliferation by glucose is associated with decreased STAT5B phosphorylation. by Kristen R. Taylor (246328)

FABP5 down regulation increases inflammation but decreases innate immunity in primary NHBE cells. by Fabienne Gally (260470)

“…</b> CS exposure significantly enhances IL-8 secretion in the basolateral supernatant of primary NHBE cell cultures knocked down for FABP5. <b>C.</b> CS exposure decreases β-defensin 2 mRNA expression on FABP5 knocked down primary NHBE cells. …”

Promoter reporter studies for reported <i>NR5A1</i> mutations by Jana Malikova (615672)

Subjects:

Promoter reporter studies for SF-1 regulating the human <i>BDNF</i> promoter I and comparative studies of specific <i>NR5A1</i> mutations on <i>BDNF</i> promoter activity. by Jana Malikova (615672)

Subjects:

Berberine decreases IBMX- and FSK-induced CRE luciferase activity. by Juan Zhang (48597)

Deletion of <i>VdSep5</i> decreased secretory protein delivery to the hyphal neck. by Ting-Ting Zhou (2236807)

Rabankyrin-5 Overexpression Increases, whereas Knock-Down Decreases Fluid-Phase Uptake, Specifically by Carsten Schnatwinkel (48)

Decreased tumorigenicity of Daoy cells over-expressing miR-199b-5p. by Livia Garzia (266719)

TG6-44 treatment leads to decrease in A/X31-induced cell death in THP-1 cells. by Juan A. De La Cruz (11154187)

Retigabine and ML213 decrease the constriction tone of human detrusor strips. by Julie Svalø (693320)

“…<p>(A) The original DSM tension recordings illustrate the relaxatory effect of retigabine and ML213, which are K_v7.2–7.5 and K_v7.2/7.4/7.5 channel activators, respectively. …”

Glucose-lowering efficacy. by Sungmin Kim (628527)

Subjects:

Clinical factors affecting renal response to dulaglutide. by Sungmin Kim (628527)

Subjects:

Flow chart of the expression-based functional screen, with validation steps. by Mohamad Karaky (8910497)

Subjects:

eGFR values and mean eGFR change after the use of dulaglutide. by Sungmin Kim (628527)

Subjects:

Antidepressants decrease β-catenin-induced liver enlargement and tumorigenesis. by Kimberley J. Evason (764570)

HSC activation results in redistribution of LDs and is accompanied by a decrease in size. by Nicole Testerink (169448)

PGC-1β KO mice show a specific decrease in Mfn2 expression in skeletal muscle. by Marc Liesa (35879)

FABP5 expression levels in brain microvessels from 2-, 8-, 12-, and 24-month-old mice. by Takuro Iwao (14636741)

Subjects:

TG6-44 treatment decreases IFN-β levels in A/X31-infected THP-1 cells. by Juan A. De La Cruz (11154187)

Loss of <i>SLC4A11</i> expression in hCEnC leads to decreased cell barrier function. by Doug D. Chung (3611387)